Cancer,geneA,geneB,p-Value,Log Odds Ratio,Association
Pan-Lung,MYC,TP53,0.142043845,0.267194001,Tendency towards co-occurrence
Pan-Lung,MYC,GSTA1,0.079758521,0.798507696,Tendency towards co-occurrence
Pan-Lung,MYC,GSTM2,0.01617119,1.432006341,Tendency towards co-occurrence(Significant)
Pan-Lung,MYC,GSTP1,0.39279971,0.33332758,Tendency towards co-occurrence
Pan-Lung,MYC,PIK3CA,0.295543385,-0.164303051,Tendency towards mutual exclusivity
Pan-Lung,MYC,RALBP1,0.259268824,0.610170485,Tendency towards co-occurrence
Pan-Lung,TP53,GSTA1,0.001746421,1.587756846,Tendency towards co-occurrence(Significant)
Pan-Lung,TP53,GSTM2,0.315296522,0.438550833,Tendency towards co-occurrence
Pan-Lung,TP53,GSTP1,0.301911939,0.359573115,Tendency towards co-occurrence
Pan-Lung,TP53,PIK3CA,1.06E-13,1.242554339,Tendency towards co-occurrence(Significant)
Pan-Lung,TP53,RALBP1,0.093316064,0.940555354,Tendency towards co-occurrence
Pan-Lung,GSTA1,GSTM2,0.083791911,1.550532242,Tendency towards co-occurrence
Pan-Lung,GSTA1,GSTP1,0.49176395,#NAME?,Tendency towards mutual exclusivity
Pan-Lung,GSTA1,PIK3CA,0.147562187,0.467642353,Tendency towards co-occurrence
Pan-Lung,GSTA1,RALBP1,0.42914858,0.640573827,Tendency towards co-occurrence
Pan-Lung,GSTM2,GSTP1,0.695579468,#NAME?,Tendency towards mutual exclusivity
Pan-Lung,GSTM2,PIK3CA,0.089884686,0.803217776,Tendency towards co-occurrence
Pan-Lung,GSTM2,RALBP1,0.750706116,#NAME?,Tendency towards mutual exclusivity
Pan-Lung,GSTP1,PIK3CA,0.353131569,0.264397554,Tendency towards co-occurrence
Pan-Lung,GSTP1,RALBP1,0.666256647,#NAME?,Tendency towards mutual exclusivity
Pan-Lung,PIK3CA,RALBP1,0.298584063,0.379489622,Tendency towards co-occurrence
Bladder Uroethelial,MYC,TP53,0.469252853,-0.16034265,Tendency towards mutual exclusivity
Bladder Uroethelial,MYC,GSTA1,0.589517445,-0.384845821,Tendency towards mutual exclusivity
Bladder Uroethelial,MYC,GSTM2,0.149919317,#NAME?,Tendency towards mutual exclusivity
Bladder Uroethelial,MYC,GSTP1,0.593288161,-0.172416028,Tendency towards mutual exclusivity
Bladder Uroethelial,MYC,PIK3CA,0.174307731,0.611082228,Tendency towards co-occurrence
Bladder Uroethelial,MYC,RALBP1,0.319156086,0.481053465,Tendency towards co-occurrence
Bladder Uroethelial,TP53,GSTA1,0.379604971,0.485507816,Tendency towards co-occurrence
Bladder Uroethelial,TP53,GSTM2,0.145735166,-0.878069519,Tendency towards mutual exclusivity
Bladder Uroethelial,TP53,GSTP1,0.273472785,0.510825624,Tendency towards co-occurrence
Bladder Uroethelial,TP53,PIK3CA,0.006793471,1.098612289,Tendency towards co-occurrence(Significant)
Bladder Uroethelial,TP53,RALBP1,0.17571568,0.621958919,Tendency towards co-occurrence
Bladder Uroethelial,GSTA1,GSTM2,0.423915006,#NAME?,Tendency towards mutual exclusivity
Bladder Uroethelial,GSTA1,GSTP1,0.705606712,-0.093526058,Tendency towards mutual exclusivity
Bladder Uroethelial,GSTA1,PIK3CA,0.552573442,0.145953913,Tendency towards co-occurrence
Bladder Uroethelial,GSTA1,RALBP1,0.214768437,#NAME?,Tendency towards mutual exclusivity
Bladder Uroethelial,GSTM2,GSTP1,0.609292662,-0.336472237,Tendency towards mutual exclusivity
Bladder Uroethelial,GSTM2,PIK3CA,0.29154751,-0.730887509,Tendency towards mutual exclusivity
Bladder Uroethelial,GSTM2,RALBP1,0.063263834,1.327453861,Tendency towards co-occurrence
Bladder Uroethelial,GSTP1,PIK3CA,0.042861621,1.114360646,Tendency towards co-occurrence(Significant)
Bladder Uroethelial,GSTP1,RALBP1,0.593288161,-0.172416028,Tendency towards mutual exclusivity
Bladder Uroethelial,PIK3CA,RALBP1,0.174307731,0.611082228,Tendency towards co-occurrence
Acute Myeloid Leukemia,MYC,TP53,0.117228387,0.988376459,Tendency towards co-occurrence
Acute Myeloid Leukemia,MYC,GSTA1,0.68217014,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,MYC,GSTM2,0.619006238,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,MYC,GSTP1,0.189369198,1.152100974,Tendency towards co-occurrence
Acute Myeloid Leukemia,MYC,PIK3CA,0.460718225,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,MYC,RALBP1,0.622859619,0.119545151,Tendency towards co-occurrence
Acute Myeloid Leukemia,TP53,GSTA1,0.085468073,1.960094784,Tendency towards co-occurrence
Acute Myeloid Leukemia,TP53,GSTM2,0.48662624,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,TP53,GSTP1,0.002319052,2.33157263,Tendency towards co-occurrence(Significant)
Acute Myeloid Leukemia,TP53,PIK3CA,0.286669548,0.832909123,Tendency towards co-occurrence
Acute Myeloid Leukemia,TP53,RALBP1,0.028770685,1.631416819,Tendency towards co-occurrence(Significant)
Acute Myeloid Leukemia,GSTA1,GSTM2,0.883845968,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,GSTA1,GSTP1,0.798460038,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,GSTA1,PIK3CA,0.81919926,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,GSTA1,RALBP1,0.778117107,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,GSTM2,GSTP1,0.754101147,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,GSTM2,PIK3CA,0.778744975,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,GSTM2,RALBP1,0.730085187,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,GSTP1,PIK3CA,0.366132606,0.985283603,Tendency towards co-occurrence
Acute Myeloid Leukemia,GSTP1,RALBP1,0.436505532,0.720546155,Tendency towards co-occurrence
Acute Myeloid Leukemia,PIK3CA,RALBP1,0.398431581,0.86081158,Tendency towards co-occurrence
Colorectal Adenocarcinoma,MYC,TP53,0.002688887,1.262793634,Tendency towards co-occurrence(Significant)
Colorectal Adenocarcinoma,MYC,GSTA1,0.468987838,0.356674944,Tendency towards co-occurrence
Colorectal Adenocarcinoma,MYC,GSTM2,0.239742796,-1.107580959,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,MYC,GSTP1,0.529149719,0.216671037,Tendency towards co-occurrence
Colorectal Adenocarcinoma,MYC,PIK3CA,0.370192939,-0.286681572,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,MYC,RALBP1,0.184480142,-0.890240055,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,TP53,GSTA1,0.354612141,-0.482654747,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,TP53,GSTM2,0.314182235,-0.401795379,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,TP53,GSTP1,0.021123339,-1.702414369,Tendency towards mutual exclusivity(Significant)
Colorectal Adenocarcinoma,TP53,PIK3CA,0.188669681,-0.364973747,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,TP53,RALBP1,0.319216306,0.311336263,Tendency towards co-occurrence
Colorectal Adenocarcinoma,GSTA1,GSTM2,0.521094073,0.428995606,Tendency towards co-occurrence
Colorectal Adenocarcinoma,GSTA1,GSTP1,0.616263295,#NAME?,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,GSTA1,PIK3CA,0.315444212,0.601579987,Tendency towards co-occurrence
Colorectal Adenocarcinoma,GSTA1,RALBP1,0.305792227,0.756061006,Tendency towards co-occurrence
Colorectal Adenocarcinoma,GSTM2,GSTP1,0.173501061,1.196250758,Tendency towards co-occurrence
Colorectal Adenocarcinoma,GSTM2,PIK3CA,0.315487138,-0.65090031,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,GSTM2,RALBP1,0.275195608,0.638087403,Tendency towards co-occurrence
Colorectal Adenocarcinoma,GSTP1,PIK3CA,0.384528298,0.440556428,Tendency towards co-occurrence
Colorectal Adenocarcinoma,GSTP1,RALBP1,0.645284117,-0.245122458,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,PIK3CA,RALBP1,0.55811022,-0.082238098,Tendency towards mutual exclusivity
Breast Cancer (Cell),MYC,TP53,5.42E-15,1.351337968,Tendency towards co-occurrence(Significant)
Breast Cancer (Cell),MYC,GSTA1,0.052172426,0.883190783,Tendency towards co-occurrence
Breast Cancer (Cell),MYC,GSTM2,0.26437299,0.387510483,Tendency towards co-occurrence
Breast Cancer (Cell),MYC,GSTP1,0.442588298,0.085309249,Tendency towards co-occurrence
Breast Cancer (Cell),MYC,PIK3CA,0.086175791,-0.255090119,Tendency towards mutual exclusivity
Breast Cancer (Cell),MYC,RALBP1,0.057990926,0.481144172,Tendency towards co-occurrence
Breast Cancer (Cell),TP53,GSTA1,0.000454313,1.693441236,Tendency towards co-occurrence(Significant)
Breast Cancer (Cell),TP53,GSTM2,0.022569771,0.917979446,Tendency towards co-occurrence(Significant)
Breast Cancer (Cell),TP53,GSTP1,0.482157901,0.045657002,Tendency towards co-occurrence
Breast Cancer (Cell),TP53,PIK3CA,0.018232644,-0.325928935,Tendency towards mutual exclusivity(Significant)
Breast Cancer (Cell),TP53,RALBP1,1.51382E-05,1.093099436,Tendency towards co-occurrence(Significant)
Breast Cancer (Cell),GSTA1,GSTM2,0.546494331,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Cell),GSTA1,GSTP1,0.191338251,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Cell),GSTA1,PIK3CA,0.552152172,0.038890871,Tendency towards co-occurrence
Breast Cancer (Cell),GSTA1,RALBP1,0.235218696,0.668788737,Tendency towards co-occurrence
Breast Cancer (Cell),GSTM2,GSTP1,0.424861559,-0.68695521,Tendency towards mutual exclusivity
Breast Cancer (Cell),GSTM2,PIK3CA,0.35917783,-0.257072823,Tendency towards mutual exclusivity
Breast Cancer (Cell),GSTM2,RALBP1,0.044681042,1.096416898,Tendency towards co-occurrence(Significant)
Breast Cancer (Cell),GSTP1,PIK3CA,0.448123964,-0.073117589,Tendency towards mutual exclusivity
Breast Cancer (Cell),GSTP1,RALBP1,0.538610058,-0.093193777,Tendency towards mutual exclusivity
Breast Cancer (Cell),PIK3CA,RALBP1,0.185628334,-0.272039295,Tendency towards mutual exclusivity
Breast Cancer (Nature),MYC,TP53,1.19465E-05,1.084830149,Tendency towards co-occurrence(Significant)
Breast Cancer (Nature),MYC,GSTA1,0.262522772,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),MYC,GSTM2,0.454118402,-0.292478245,Tendency towards mutual exclusivity
Breast Cancer (Nature),MYC,GSTP1,0.219910721,-0.549388659,Tendency towards mutual exclusivity
Breast Cancer (Nature),MYC,PIK3CA,0.381479879,-0.106965992,Tendency towards mutual exclusivity
Breast Cancer (Nature),MYC,RALBP1,0.101349382,0.509107731,Tendency towards co-occurrence
Breast Cancer (Nature),TP53,GSTA1,0.300374332,0.678548381,Tendency towards co-occurrence
Breast Cancer (Nature),TP53,GSTM2,0.396135257,0.208048925,Tendency towards co-occurrence
Breast Cancer (Nature),TP53,GSTP1,0.374577598,0.170625517,Tendency towards co-occurrence
Breast Cancer (Nature),TP53,PIK3CA,0.02651283,-0.390294766,Tendency towards mutual exclusivity(Significant)
Breast Cancer (Nature),TP53,RALBP1,0.000208514,1.090146388,Tendency towards co-occurrence(Significant)
Breast Cancer (Nature),GSTA1,GSTM2,0.709595729,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),GSTA1,GSTP1,0.565263688,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),GSTA1,PIK3CA,0.116515553,-1.544899391,Tendency towards mutual exclusivity
Breast Cancer (Nature),GSTA1,RALBP1,0.185730048,1.155770703,Tendency towards co-occurrence
Breast Cancer (Nature),GSTM2,GSTP1,0.523917023,0.179867568,Tendency towards co-occurrence
Breast Cancer (Nature),GSTM2,PIK3CA,0.324681675,-0.308877231,Tendency towards mutual exclusivity
Breast Cancer (Nature),GSTM2,RALBP1,0.47157718,0.210857864,Tendency towards co-occurrence
Breast Cancer (Nature),GSTP1,PIK3CA,0.229161374,-0.330523269,Tendency towards mutual exclusivity
Breast Cancer (Nature),GSTP1,RALBP1,0.063526969,-1.579665754,Tendency towards mutual exclusivity
Breast Cancer (Nature),PIK3CA,RALBP1,0.230980562,0.257059212,Tendency towards co-occurrence
LGG+GBM,MYC,TP53,1.76962E-05,2.042034365,Tendency towards co-occurrence(Significant)
LGG+GBM,MYC,GSTA1,0.194006489,1.711314104,Tendency towards co-occurrence
LGG+GBM,MYC,GSTM2,0.884256568,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,MYC,GSTP1,0.857393077,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,MYC,PIK3CA,0.643949193,-0.063469574,Tendency towards mutual exclusivity
LGG+GBM,MYC,RALBP1,0.911925613,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,TP53,GSTA1,0.30236694,0.670959266,Tendency towards co-occurrence
LGG+GBM,TP53,GSTM2,0.463243059,-0.724695538,Tendency towards mutual exclusivity
LGG+GBM,TP53,GSTP1,0.3288453,0.787746881,Tendency towards co-occurrence
LGG+GBM,TP53,PIK3CA,0.036217758,-0.512719564,Tendency towards mutual exclusivity(Significant)
LGG+GBM,TP53,RALBP1,0.361650122,1.074438752,Tendency towards co-occurrence
LGG+GBM,GSTA1,GSTM2,0.965134061,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,GSTA1,GSTP1,0.956582241,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,GSTA1,PIK3CA,0.522768595,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,GSTA1,RALBP1,0.97375133,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,GSTM2,GSTP1,0.975001187,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,GSTM2,PIK3CA,0.690802612,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,GSTM2,RALBP1,0.984943777,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,GSTP1,PIK3CA,0.629592254,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,GSTP1,RALBP1,0.981203484,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,PIK3CA,RALBP1,0.757870827,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),MYC,TP53,0.420910837,0.28611835,Tendency towards co-occurrence
Glioblastoma (Cell),MYC,GSTA1,0.219861806,1.658228077,Tendency towards co-occurrence
Glioblastoma (Cell),MYC,GSTM2,0.637543924,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),MYC,GSTP1,0.741949611,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),MYC,PIK3CA,0.229534482,0.736239324,Tendency towards co-occurrence
Glioblastoma (Cell),MYC,RALBP1,0.820145281,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),TP53,GSTA1,0.085276395,1.62924054,Tendency towards co-occurrence
Glioblastoma (Cell),TP53,GSTM2,0.353002723,0.512362903,Tendency towards co-occurrence
Glioblastoma (Cell),TP53,GSTP1,0.142338595,1.219240276,Tendency towards co-occurrence
Glioblastoma (Cell),TP53,PIK3CA,0.43442457,0.144794324,Tendency towards co-occurrence
Glioblastoma (Cell),TP53,RALBP1,0.040969274,2.326902401,Tendency towards co-occurrence(Significant)
Glioblastoma (Cell),GSTA1,GSTM2,0.146311867,2.161885211,Tendency towards co-occurrence
Glioblastoma (Cell),GSTA1,GSTP1,0.900413193,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),GSTA1,PIK3CA,0.5244109,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),GSTA1,RALBP1,0.067316376,3.160540248,Tendency towards co-occurrence
Glioblastoma (Cell),GSTM2,GSTP1,0.173176178,1.935138052,Tendency towards co-occurrence
Glioblastoma (Cell),GSTM2,PIK3CA,0.310185005,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),GSTM2,RALBP1,0.881325519,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),GSTP1,PIK3CA,0.539765259,0.389654502,Tendency towards co-occurrence
Glioblastoma (Cell),GSTP1,RALBP1,0.919639097,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),PIK3CA,RALBP1,0.597245747,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Nature),MYC,TP53,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),MYC,GSTA1,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),MYC,GSTM2,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),MYC,GSTP1,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),MYC,PIK3CA,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),MYC,RALBP1,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),TP53,GSTA1,0.351648352,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),TP53,GSTM2,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),TP53,GSTP1,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),TP53,PIK3CA,0.582491395,0.110862593,Tendency towards co-occurrence
Glioblastoma (Nature),TP53,RALBP1,0.351648352,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),GSTA1,GSTM2,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),GSTA1,GSTP1,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),GSTA1,PIK3CA,0.912087912,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Nature),GSTA1,RALBP1,0.989010989,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Nature),GSTM2,GSTP1,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),GSTM2,PIK3CA,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),GSTM2,RALBP1,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),GSTP1,PIK3CA,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),GSTP1,RALBP1,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),PIK3CA,RALBP1,0.087912088,Infinity,Tendency towards co-occurrence
Stomach +Esophageal Cancer,MYC,TP53,0.312556115,0.221394897,Tendency towards co-occurrence
Stomach +Esophageal Cancer,MYC,GSTA1,0.421318194,-0.353863979,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,MYC,GSTM2,0.133474424,1.928815716,Tendency towards co-occurrence
Stomach +Esophageal Cancer,MYC,GSTP1,0.245384335,0.549359288,Tendency towards co-occurrence
Stomach +Esophageal Cancer,MYC,PIK3CA,0.154595091,-0.618423634,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,MYC,RALBP1,0.245384335,0.549359288,Tendency towards co-occurrence
Stomach +Esophageal Cancer,TP53,GSTA1,0.025392657,1.898262189,Tendency towards co-occurrence(Significant)
Stomach +Esophageal Cancer,TP53,GSTM2,0.372771948,Infinity,Tendency towards co-occurrence
Stomach +Esophageal Cancer,TP53,GSTP1,0.412195788,-0.271243346,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,TP53,PIK3CA,0.333654219,-0.24323031,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,TP53,RALBP1,0.158405374,0.966684746,Tendency towards co-occurrence
Stomach +Esophageal Cancer,GSTA1,GSTM2,0.818989232,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,GSTA1,GSTP1,0.3596057,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,GSTA1,PIK3CA,0.330151869,-0.898458256,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,GSTA1,RALBP1,0.6403943,0.043675064,Tendency towards co-occurrence
Stomach +Esophageal Cancer,GSTM2,GSTP1,0.008708398,3.64565072,Tendency towards co-occurrence(Significant)
Stomach +Esophageal Cancer,GSTM2,PIK3CA,0.661256188,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,GSTM2,RALBP1,0.160954549,2.181224236,Tendency towards co-occurrence
Stomach +Esophageal Cancer,GSTP1,PIK3CA,0.299215403,0.568790164,Tendency towards co-occurrence
Stomach +Esophageal Cancer,GSTP1,RALBP1,0.407082285,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,PIK3CA,RALBP1,0.598023324,0.046956983,Tendency towards co-occurrence
Stomach Adenocarcinoma,MYC,TP53,0.108031706,0.423814247,Tendency towards co-occurrence
Stomach Adenocarcinoma,MYC,GSTA1,0.018909009,#NAME?,Tendency towards mutual exclusivity(Significant)
Stomach Adenocarcinoma,MYC,GSTM2,0.381564263,1.319283651,Tendency towards co-occurrence
Stomach Adenocarcinoma,MYC,GSTP1,0.476621374,-0.215547204,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,MYC,PIK3CA,0.134571702,-0.442394077,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,MYC,RALBP1,0.366026749,0.238625915,Tendency towards co-occurrence
Stomach Adenocarcinoma,TP53,GSTA1,0.337513507,0.350569386,Tendency towards co-occurrence
Stomach Adenocarcinoma,TP53,GSTM2,0.230024432,Infinity,Tendency towards co-occurrence
Stomach Adenocarcinoma,TP53,GSTP1,0.19510314,0.486508316,Tendency towards co-occurrence
Stomach Adenocarcinoma,TP53,PIK3CA,0.000898001,-0.9027137,Tendency towards mutual exclusivity(Significant)
Stomach Adenocarcinoma,TP53,RALBP1,0.335689529,0.231457802,Tendency towards co-occurrence
Stomach Adenocarcinoma,GSTA1,GSTM2,0.879588574,#NAME?,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,GSTA1,GSTP1,0.404639099,0.461034959,Tendency towards co-occurrence
Stomach Adenocarcinoma,GSTA1,PIK3CA,0.57573307,0.031441526,Tendency towards co-occurrence
Stomach Adenocarcinoma,GSTA1,RALBP1,0.615598477,0.009478744,Tendency towards co-occurrence
Stomach Adenocarcinoma,GSTM2,GSTP1,0.16357494,2.415063076,Tendency towards co-occurrence
Stomach Adenocarcinoma,GSTM2,PIK3CA,0.480529665,#NAME?,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,GSTM2,RALBP1,0.766898923,#NAME?,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,GSTP1,PIK3CA,0.281295475,-0.44024419,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,GSTP1,RALBP1,0.283440532,0.501256173,Tendency towards co-occurrence
Stomach Adenocarcinoma,PIK3CA,RALBP1,0.302786806,-0.317867049,Tendency towards mutual exclusivity
Head and Neck Cancer,MYC,TP53,0.029961378,0.804433356,Tendency towards co-occurrence(Significant)
Head and Neck Cancer,MYC,GSTA1,0.531570792,0.101303715,Tendency towards co-occurrence
Head and Neck Cancer,MYC,GSTM2,0.171899212,-0.914298699,Tendency towards mutual exclusivity
Head and Neck Cancer,MYC,GSTP1,0.355040734,0.209720531,Tendency towards co-occurrence
Head and Neck Cancer,MYC,PIK3CA,0.272934305,-0.216793466,Tendency towards mutual exclusivity
Head and Neck Cancer,MYC,RALBP1,0.282875735,0.347830919,Tendency towards co-occurrence
Head and Neck Cancer,TP53,GSTA1,0.560871351,-0.057013539,Tendency towards mutual exclusivity
Head and Neck Cancer,TP53,GSTM2,0.34120832,0.470003629,Tendency towards co-occurrence
Head and Neck Cancer,TP53,GSTP1,0.08448808,0.707094408,Tendency towards co-occurrence
Head and Neck Cancer,TP53,PIK3CA,0.268767003,0.217465844,Tendency towards co-occurrence
Head and Neck Cancer,TP53,RALBP1,0.178228739,-0.490622916,Tendency towards mutual exclusivity
Head and Neck Cancer,GSTA1,GSTM2,0.098928151,1.192297773,Tendency towards co-occurrence
Head and Neck Cancer,GSTA1,GSTP1,0.216985461,-1.144717108,Tendency towards mutual exclusivity
Head and Neck Cancer,GSTA1,PIK3CA,0.040735458,1.102282018,Tendency towards co-occurrence(Significant)
Head and Neck Cancer,GSTA1,RALBP1,0.086062749,1.07052932,Tendency towards co-occurrence
Head and Neck Cancer,GSTM2,GSTP1,0.0592335,0.991901334,Tendency towards co-occurrence
Head and Neck Cancer,GSTM2,PIK3CA,0.43531406,0.195221091,Tendency towards co-occurrence
Head and Neck Cancer,GSTM2,RALBP1,0.115339677,#NAME?,Tendency towards mutual exclusivity
Head and Neck Cancer,GSTP1,PIK3CA,0.254969515,-0.270173208,Tendency towards mutual exclusivity
Head and Neck Cancer,GSTP1,RALBP1,0.296409588,0.375265368,Tendency towards co-occurrence
Head and Neck Cancer,PIK3CA,RALBP1,0.120113135,-0.540899801,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,MYC,TP53,0.175547356,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,MYC,GSTA1,0.586346033,0.191350964,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,MYC,GSTM2,0.389515008,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,MYC,GSTP1,0.389515008,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,MYC,PIK3CA,0.53443066,0.162001554,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,MYC,RALBP1,0.412718921,-0.720947069,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,TP53,GSTA1,0.693841215,-0.116189918,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,TP53,GSTM2,0.665248858,-0.188052232,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,TP53,GSTP1,0.334751142,0.613324907,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,TP53,PIK3CA,0.06706334,0.993370474,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,TP53,RALBP1,0.529529541,-0.266307213,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,GSTA1,GSTM2,0.471009104,0.544536681,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,GSTA1,GSTP1,0.471009104,0.544536681,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,GSTA1,PIK3CA,0.283833061,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,GSTA1,RALBP1,0.620171629,-0.294923234,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,GSTM2,GSTP1,0.022618445,1.863116408,Tendency towards co-occurrence(Significant)
Kidney Clear Cell Carcinoma,GSTM2,PIK3CA,0.260494003,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,GSTM2,RALBP1,0.152896847,0.943220144,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,GSTP1,PIK3CA,0.633918933,-0.262808808,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,GSTP1,RALBP1,0.040637001,1.346629105,Tendency towards co-occurrence(Significant)
Kidney Clear Cell Carcinoma,PIK3CA,RALBP1,0.276144304,0.491378489,Tendency towards co-occurrence
Kidney Chromophobe Cancer,MYC,TP53,0.554761759,0.287682072,Tendency towards co-occurrence
Kidney Chromophobe Cancer,MYC,GSTA1,0.850961538,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,MYC,GSTM2,0.076923077,Infinity,Tendency towards co-occurrence
Kidney Chromophobe Cancer,MYC,GSTP1,0.149038462,2.691243083,Tendency towards co-occurrence
Kidney Chromophobe Cancer,MYC,PIK3CA,0.923076923,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,MYC,RALBP1,0.149038462,2.691243083,Tendency towards co-occurrence
Kidney Chromophobe Cancer,TP53,GSTA1,0.434134615,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,TP53,GSTM2,0.661538462,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,TP53,GSTP1,0.434134615,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,TP53,PIK3CA,0.661538462,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,TP53,RALBP1,0.434134615,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,GSTA1,GSTM2,0.969230769,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,GSTA1,GSTP1,0.938942308,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,GSTA1,PIK3CA,0.969230769,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,GSTA1,RALBP1,0.938942308,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,GSTM2,GSTP1,0.969230769,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,GSTM2,PIK3CA,0.984615385,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,GSTM2,RALBP1,0.030769231,Infinity,Tendency towards co-occurrence(Significant)
Kidney Chromophobe Cancer,GSTP1,PIK3CA,0.969230769,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,GSTP1,RALBP1,0.938942308,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,PIK3CA,RALBP1,0.969230769,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,MYC,TP53,0.281385688,0.342258174,Tendency towards co-occurrence
Lung Adenocarcinoma,MYC,GSTA1,0.591859282,0.21190046,Tendency towards co-occurrence
Lung Adenocarcinoma,MYC,GSTM2,0.42658877,0.78647912,Tendency towards co-occurrence
Lung Adenocarcinoma,MYC,GSTP1,0.42658877,0.78647912,Tendency towards co-occurrence
Lung Adenocarcinoma,MYC,PIK3CA,0.409617869,0.340759489,Tendency towards co-occurrence
Lung Adenocarcinoma,MYC,RALBP1,0.717386308,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,TP53,GSTA1,0.020574651,2.144761008,Tendency towards co-occurrence(Significant)
Lung Adenocarcinoma,TP53,GSTM2,0.565578414,-0.271933715,Tendency towards mutual exclusivity
Lung Adenocarcinoma,TP53,GSTP1,0.565578414,-0.271933715,Tendency towards mutual exclusivity
Lung Adenocarcinoma,TP53,PIK3CA,1.54E-01,0.560628446,Tendency towards co-occurrence
Lung Adenocarcinoma,TP53,RALBP1,0.552317808,-0.560795729,Tendency towards mutual exclusivity
Lung Adenocarcinoma,GSTA1,GSTM2,0.83644247,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,GSTA1,GSTP1,0.83644247,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,GSTA1,PIK3CA,0.031182299,1.857941376,Tendency towards co-occurrence(Significant)
Lung Adenocarcinoma,GSTA1,RALBP1,0.898813866,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,GSTM2,GSTP1,0.895051832,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,GSTM2,PIK3CA,0.397922403,0.887303195,Tendency towards co-occurrence
Lung Adenocarcinoma,GSTM2,RALBP1,0.935916781,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,GSTP1,PIK3CA,0.602077597,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,GSTP1,RALBP1,0.935916781,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,PIK3CA,RALBP1,0.26141117,1.590206551,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,MYC,TP53,0.29371338,Infinity,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,MYC,GSTA1,0.33831625,-0.893168314,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,MYC,GSTM2,0.29402261,0.596154915,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,MYC,GSTP1,0.484027232,0.301475395,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,MYC,PIK3CA,0.26383198,-0.423814247,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,MYC,RALBP1,0.515972768,-0.532654594,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,TP53,GSTA1,0.289568443,-0.797772132,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,TP53,GSTM2,0.356461179,Infinity,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,TP53,GSTP1,0.431025502,Infinity,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,TP53,PIK3CA,0.611653855,-0.072657646,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,TP53,RALBP1,0.568974498,-0.281251182,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,GSTA1,GSTM2,0.566284524,0.121696935,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,GSTA1,GSTP1,0.046742113,1.379605373,Tendency towards co-occurrence(Significant)
Lung Squamous Cell Carcinoma,GSTA1,PIK3CA,0.093637804,0.980829253,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,GSTA1,RALBP1,0.544727544,-0.471714494,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,GSTM2,GSTP1,0.395722766,0.504136636,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,GSTM2,PIK3CA,0.011096091,2.116482813,Tendency towards co-occurrence(Significant)
Lung Squamous Cell Carcinoma,GSTM2,RALBP1,0.604277234,-0.340325806,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,GSTP1,PIK3CA,0.124074192,1.08026315,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,GSTP1,RALBP1,0.303331748,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,PIK3CA,RALBP1,0.302857505,0.560044696,Tendency towards co-occurrence
Ovarian Serous Cancer,MYC,TP53,0.049194835,1.758550798,Tendency towards co-occurrence(Significant)
Ovarian Serous Cancer,MYC,GSTA1,0.264035226,0.45687063,Tendency towards co-occurrence
Ovarian Serous Cancer,MYC,GSTM2,0.160214647,0.541597282,Tendency towards co-occurrence
Ovarian Serous Cancer,MYC,GSTP1,0.418778293,-0.166148698,Tendency towards mutual exclusivity
Ovarian Serous Cancer,MYC,PIK3CA,0.151457661,0.278359629,Tendency towards co-occurrence
Ovarian Serous Cancer,MYC,RALBP1,0.167311172,-0.463837114,Tendency towards mutual exclusivity
Ovarian Serous Cancer,TP53,GSTA1,0.117945108,-1.421385681,Tendency towards mutual exclusivity
Ovarian Serous Cancer,TP53,GSTM2,0.586038884,-0.203029187,Tendency towards mutual exclusivity
Ovarian Serous Cancer,TP53,GSTP1,0.259618369,Infinity,Tendency towards co-occurrence
Ovarian Serous Cancer,TP53,PIK3CA,0.018277525,2.038823204,Tendency towards co-occurrence(Significant)
Ovarian Serous Cancer,TP53,RALBP1,0.593806061,0.358531955,Tendency towards co-occurrence
Ovarian Serous Cancer,GSTA1,GSTM2,0.307830088,0.693147181,Tendency towards co-occurrence
Ovarian Serous Cancer,GSTA1,GSTP1,0.485785077,-0.582799123,Tendency towards mutual exclusivity
Ovarian Serous Cancer,GSTA1,PIK3CA,0.468529736,0.16805911,Tendency towards co-occurrence
Ovarian Serous Cancer,GSTA1,RALBP1,0.43562513,-0.683668437,Tendency towards mutual exclusivity
Ovarian Serous Cancer,GSTM2,GSTP1,0.409431018,0.328925031,Tendency towards co-occurrence
Ovarian Serous Cancer,GSTM2,PIK3CA,0.109914929,0.639079959,Tendency towards co-occurrence
Ovarian Serous Cancer,GSTM2,RALBP1,0.469468914,0.222186155,Tendency towards co-occurrence
Ovarian Serous Cancer,GSTP1,PIK3CA,0.2690176,-0.31411533,Tendency towards mutual exclusivity
Ovarian Serous Cancer,GSTP1,RALBP1,0.155774968,0.62811471,Tendency towards co-occurrence
Ovarian Serous Cancer,PIK3CA,RALBP1,0.079897293,-0.609235208,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,MYC,TP53,0.013529106,0.996156589,Tendency towards co-occurrence(Significant)
Prostate Adenocarcinoma,MYC,GSTA1,0.538854689,0.389960922,Tendency towards co-occurrence
Prostate Adenocarcinoma,MYC,GSTM2,0.307570863,-0.937162306,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,MYC,GSTP1,0.210731683,0.565166218,Tendency towards co-occurrence
Prostate Adenocarcinoma,MYC,PIK3CA,0.001365916,1.683545885,Tendency towards co-occurrence(Significant)
Prostate Adenocarcinoma,MYC,RALBP1,0.001118363,2.133121691,Tendency towards co-occurrence(Significant)
Prostate Adenocarcinoma,TP53,GSTA1,0.398361266,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,TP53,GSTM2,0.220304576,-1.128026174,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,TP53,GSTP1,0.080440653,-1.526056303,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,TP53,PIK3CA,0.408030764,-0.47070563,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,TP53,RALBP1,0.475316433,-0.609765572,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,GSTA1,GSTM2,0.040384979,2.210211773,Tendency towards co-occurrence(Significant)
Prostate Adenocarcinoma,GSTA1,GSTP1,0.0004663,3.274680666,Tendency towards co-occurrence(Significant)
Prostate Adenocarcinoma,GSTA1,PIK3CA,0.325580287,1.121677562,Tendency towards co-occurrence
Prostate Adenocarcinoma,GSTA1,RALBP1,0.800986444,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,GSTM2,GSTP1,0.012620987,1.556091932,Tendency towards co-occurrence(Significant)
Prostate Adenocarcinoma,GSTM2,PIK3CA,0.659586047,-0.202524264,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,GSTM2,RALBP1,0.488078415,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,GSTP1,PIK3CA,0.078627357,1.084013489,Tendency towards co-occurrence
Prostate Adenocarcinoma,GSTP1,RALBP1,0.643923191,0.030983546,Tendency towards co-occurrence
Prostate Adenocarcinoma,PIK3CA,RALBP1,0.170631207,1.156550126,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,MYC,TP53,0.614444008,0.108213585,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,MYC,GSTA1,0.573332012,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,MYC,GSTM2,0.681775668,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,MYC,GSTP1,0.426667988,0.693147181,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,MYC,PIK3CA,0.19648883,1.033015006,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,MYC,RALBP1,0.502851999,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,TP53,GSTA1,0.163913166,1.171637424,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,TP53,GSTM2,0.411989544,0.756569007,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,TP53,GSTP1,0.003985261,2.176433808,Tendency towards co-occurrence(Significant)
Papillary Thyroid Carcinoma,TP53,PIK3CA,0.301817701,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,TP53,RALBP1,0.614444008,0.108213585,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,GSTA1,GSTM2,0.266537582,1.341013657,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,GSTA1,GSTP1,0.065660677,1.794510503,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,GSTA1,PIK3CA,0.497000632,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,GSTA1,RALBP1,0.426667988,0.693147181,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,GSTM2,GSTP1,0.002209578,2.91506437,Tendency towards co-occurrence(Significant)
Papillary Thyroid Carcinoma,GSTM2,PIK3CA,0.07314304,1.745743232,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,GSTM2,RALBP1,6.9941E-06,3.733331217,Tendency towards co-occurrence(Significant)
Papillary Thyroid Carcinoma,GSTP1,PIK3CA,0.024112441,1.843346838,Tendency towards co-occurrence(Significant)
Papillary Thyroid Carcinoma,GSTP1,RALBP1,0.012824272,2.12272205,Tendency towards co-occurrence(Significant)
Papillary Thyroid Carcinoma,PIK3CA,RALBP1,0.04269517,1.572567377,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,MYC,TP53,3.57795E-06,1.732336049,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,MYC,GSTA1,0.529886904,0.131691466,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,MYC,GSTM2,0.514604053,-0.302761179,Tendency towards mutual exclusivity
Uterine Corpus Endometrial Cancer,MYC,GSTP1,0.187018429,0.583817281,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,MYC,PIK3CA,0.099965948,0.560543002,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,MYC,RALBP1,0.004012029,1.424459769,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,TP53,GSTA1,0.247636031,0.47957308,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,TP53,GSTM2,0.081034593,0.864997437,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,TP53,GSTP1,6.18388E-05,1.770319138,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,TP53,PIK3CA,0.144097372,0.354518775,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,TP53,RALBP1,1.16883E-06,2.335374916,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,GSTA1,GSTM2,0.283516296,#NAME?,Tendency towards mutual exclusivity
Uterine Corpus Endometrial Cancer,GSTA1,GSTP1,0.271832353,0.631202695,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,GSTA1,PIK3CA,0.573172132,-0.029447201,Tendency towards mutual exclusivity
Uterine Corpus Endometrial Cancer,GSTA1,RALBP1,0.002931776,1.848917883,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,GSTM2,GSTP1,0.078152172,1.129864832,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,GSTM2,PIK3CA,0.147340302,0.762140052,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,GSTM2,RALBP1,0.513475906,-0.531234495,Tendency towards mutual exclusivity
Uterine Corpus Endometrial Cancer,GSTP1,PIK3CA,0.432489547,-0.160278901,Tendency towards mutual exclusivity
Uterine Corpus Endometrial Cancer,GSTP1,RALBP1,0.223438534,0.633774907,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,PIK3CA,RALBP1,0.012819385,1.278830795,Tendency towards co-occurrence(Significant)
Pan-Lung,PTPN6,COL18A1,0.406807407,#NAME?,Tendency towards mutual exclusivity
Pan-Lung,PTPN6,FOXO4,0.607734412,0.101352494,Tendency towards co-occurrence
Pan-Lung,PTPN6,CUX2,0.44814363,0.227088965,Tendency towards co-occurrence
Pan-Lung,PTPN6,ARHGEF10L,0.70417327,-0.085613753,Tendency towards mutual exclusivity
Pan-Lung,PTPN6,TIAM1,0.612852096,-0.053601347,Tendency towards mutual exclusivity
Pan-Lung,PTPN6,ZBTB33,0.339001306,#NAME?,Tendency towards mutual exclusivity
Pan-Lung,PTPN6,RALBP1,0.49424551,0.436323096,Tendency towards co-occurrence
Pan-Lung,COL18A1,FOXO4,0.440619886,0.600666328,Tendency towards co-occurrence
Pan-Lung,COL18A1,CUX2,0.540618595,-0.455614892,Tendency towards mutual exclusivity
Pan-Lung,COL18A1,ARHGEF10L,0.499470361,#NAME?,Tendency towards mutual exclusivity
Pan-Lung,COL18A1,TIAM1,0.010459552,1.358660397,Tendency towards co-occurrence(Significant)
Pan-Lung,COL18A1,ZBTB33,0.137501481,1.22029844,Tendency towards co-occurrence
Pan-Lung,COL18A1,RALBP1,0.062481718,1.72932161,Tendency towards co-occurrence
Pan-Lung,FOXO4,CUX2,0.069169387,1.064045559,Tendency towards co-occurrence
Pan-Lung,FOXO4,ARHGEF10L,0.154605126,1.140812643,Tendency towards co-occurrence
Pan-Lung,FOXO4,TIAM1,0.664127486,-0.024929383,Tendency towards mutual exclusivity
Pan-Lung,FOXO4,ZBTB33,0.49723859,#NAME?,Tendency towards mutual exclusivity
Pan-Lung,FOXO4,RALBP1,0.643833321,#NAME?,Tendency towards mutual exclusivity
Pan-Lung,CUX2,ARHGEF10L,0.293794426,0.514443804,Tendency towards co-occurrence
Pan-Lung,CUX2,TIAM1,0.006280982,0.97150207,Tendency towards co-occurrence(Significant)
Pan-Lung,CUX2,ZBTB33,0.03191439,1.171767426,Tendency towards co-occurrence(Significant)
Pan-Lung,CUX2,RALBP1,0.674084985,-0.162234798,Tendency towards mutual exclusivity
Pan-Lung,ARHGEF10L,TIAM1,0.222409029,0.570507409,Tendency towards co-occurrence
Pan-Lung,ARHGEF10L,ZBTB33,0.566096771,0.21991997,Tendency towards co-occurrence
Pan-Lung,ARHGEF10L,RALBP1,0.590861311,#NAME?,Tendency towards mutual exclusivity
Pan-Lung,TIAM1,ZBTB33,0.424693918,0.271264514,Tendency towards co-occurrence
Pan-Lung,TIAM1,RALBP1,0.448415995,0.32668423,Tendency towards co-occurrence
Pan-Lung,ZBTB33,RALBP1,0.601113699,#NAME?,Tendency towards mutual exclusivity
Bladder Uroethelial,PTPN6,COL18A1,0.568565132,#NAME?,Tendency towards mutual exclusivity
Bladder Uroethelial,PTPN6,FOXO4,0.819362681,#NAME?,Tendency towards mutual exclusivity
Bladder Uroethelial,PTPN6,CUX2,0.666775682,#NAME?,Tendency towards mutual exclusivity
Bladder Uroethelial,PTPN6,ARHGEF10L,0.180637319,2.04553999,Tendency towards co-occurrence
Bladder Uroethelial,PTPN6,TIAM1,0.695484446,-0.125769387,Tendency towards mutual exclusivity
Bladder Uroethelial,PTPN6,ZBTB33,0.367417943,1.020650747,Tendency towards co-occurrence
Bladder Uroethelial,PTPN6,RALBP1,0.636316149,0.115310847,Tendency towards co-occurrence
Bladder Uroethelial,COL18A1,FOXO4,0.688537591,#NAME?,Tendency towards mutual exclusivity
Bladder Uroethelial,COL18A1,CUX2,0.532093814,0.424333592,Tendency towards co-occurrence
Bladder Uroethelial,COL18A1,ARHGEF10L,0.688537591,#NAME?,Tendency towards mutual exclusivity
Bladder Uroethelial,COL18A1,TIAM1,0.672789011,-0.016000341,Tendency towards mutual exclusivity
Bladder Uroethelial,COL18A1,ZBTB33,0.423915006,#NAME?,Tendency towards mutual exclusivity
Bladder Uroethelial,COL18A1,RALBP1,0.476306163,-0.628608659,Tendency towards mutual exclusivity
Bladder Uroethelial,FOXO4,CUX2,0.764979686,#NAME?,Tendency towards mutual exclusivity
Bladder Uroethelial,FOXO4,ARHGEF10L,0.12340509,2.573460047,Tendency towards co-occurrence
Bladder Uroethelial,FOXO4,TIAM1,0.56150959,0.405465108,Tendency towards co-occurrence
Bladder Uroethelial,FOXO4,ZBTB33,0.738826534,#NAME?,Tendency towards mutual exclusivity
Bladder Uroethelial,FOXO4,RALBP1,0.487411229,0.645744942,Tendency towards co-occurrence
Bladder Uroethelial,CUX2,ARHGEF10L,0.235020314,1.691676011,Tendency towards co-occurrence
Bladder Uroethelial,CUX2,TIAM1,0.452432377,0.421213465,Tendency towards co-occurrence
Bladder Uroethelial,CUX2,ZBTB33,0.459859075,0.665996191,Tendency towards co-occurrence
Bladder Uroethelial,CUX2,RALBP1,0.650082941,-0.241162057,Tendency towards mutual exclusivity
Bladder Uroethelial,ARHGEF10L,TIAM1,0.56150959,0.405465108,Tendency towards co-occurrence
Bladder Uroethelial,ARHGEF10L,ZBTB33,0.261173466,1.549333988,Tendency towards co-occurrence
Bladder Uroethelial,ARHGEF10L,RALBP1,0.487411229,0.645744942,Tendency towards co-occurrence
Bladder Uroethelial,TIAM1,ZBTB33,0.214772294,0.875468737,Tendency towards co-occurrence
Bladder Uroethelial,TIAM1,RALBP1,0.250617892,0.557345639,Tendency towards co-occurrence
Bladder Uroethelial,ZBTB33,RALBP1,0.589517445,-0.384845821,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,PTPN6,COL18A1,0.398431581,0.86081158,Tendency towards co-occurrence
Acute Myeloid Leukemia,PTPN6,FOXO4,0.740049573,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,PTPN6,CUX2,0.633867394,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,PTPN6,ARHGEF10L,0.075441826,1.832581464,Tendency towards co-occurrence
Acute Myeloid Leukemia,PTPN6,TIAM1,0.429281244,0.748717032,Tendency towards co-occurrence
Acute Myeloid Leukemia,PTPN6,ZBTB33,0.049338835,2.133508763,Tendency towards co-occurrence(Significant)
Acute Myeloid Leukemia,PTPN6,RALBP1,0.398431581,0.86081158,Tendency towards co-occurrence
Acute Myeloid Leukemia,COL18A1,FOXO4,0.315261719,1.210617347,Tendency towards co-occurrence
Acute Myeloid Leukemia,COL18A1,CUX2,0.436505532,0.720546155,Tendency towards co-occurrence
Acute Myeloid Leukemia,COL18A1,ARHGEF10L,0.472396899,0.595983432,Tendency towards co-occurrence
Acute Myeloid Leukemia,COL18A1,TIAM1,0.020303713,2.070472872,Tendency towards co-occurrence(Significant)
Acute Myeloid Leukemia,COL18A1,ZBTB33,0.007613977,2.560544064,Tendency towards co-occurrence(Significant)
Acute Myeloid Leukemia,COL18A1,RALBP1,0.472396899,0.595983432,Tendency towards co-occurrence
Acute Myeloid Leukemia,FOXO4,CUX2,0.711946424,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,FOXO4,ARHGEF10L,0.684738281,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,FOXO4,TIAM1,0.658402193,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,FOXO4,ZBTB33,0.740049573,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,FOXO4,RALBP1,0.315261719,1.210617347,Tendency towards co-occurrence
Acute Myeloid Leukemia,CUX2,ARHGEF10L,0.436505532,0.720546155,Tendency towards co-occurrence
Acute Myeloid Leukemia,CUX2,TIAM1,0.530985172,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,CUX2,ZBTB33,0.061876256,1.972757399,Tendency towards co-occurrence
Acute Myeloid Leukemia,CUX2,RALBP1,0.436505532,0.720546155,Tendency towards co-occurrence
Acute Myeloid Leukemia,ARHGEF10L,TIAM1,0.493782389,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,ARHGEF10L,ZBTB33,0.398431581,0.86081158,Tendency towards co-occurrence
Acute Myeloid Leukemia,ARHGEF10L,RALBP1,0.527603101,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,TIAM1,ZBTB33,0.570718756,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,TIAM1,RALBP1,0.506217611,0.483796951,Tendency towards co-occurrence
Acute Myeloid Leukemia,ZBTB33,RALBP1,0.398431581,0.86081158,Tendency towards co-occurrence
Colorectal Adenocarcinoma,PTPN6,COL18A1,0.289283484,0.780158558,Tendency towards co-occurrence
Colorectal Adenocarcinoma,PTPN6,FOXO4,0.772418469,#NAME?,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,PTPN6,CUX2,0.004794203,2.262919837,Tendency towards co-occurrence(Significant)
Colorectal Adenocarcinoma,PTPN6,ARHGEF10L,0.321773382,0.687177014,Tendency towards co-occurrence
Colorectal Adenocarcinoma,PTPN6,TIAM1,0.171693715,0.925479158,Tendency towards co-occurrence
Colorectal Adenocarcinoma,PTPN6,ZBTB33,0.018112116,3.235873401,Tendency towards co-occurrence(Significant)
Colorectal Adenocarcinoma,PTPN6,RALBP1,0.000978375,2.003068563,Tendency towards co-occurrence(Significant)
Colorectal Adenocarcinoma,COL18A1,FOXO4,0.812136104,#NAME?,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,COL18A1,CUX2,0.493127002,#NAME?,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,COL18A1,ARHGEF10L,0.63245803,0.080042708,Tendency towards co-occurrence
Colorectal Adenocarcinoma,COL18A1,TIAM1,0.342055044,0.634650974,Tendency towards co-occurrence
Colorectal Adenocarcinoma,COL18A1,ZBTB33,0.812136104,#NAME?,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,COL18A1,RALBP1,0.012169396,1.679307592,Tendency towards co-occurrence(Significant)
Colorectal Adenocarcinoma,FOXO4,CUX2,0.146807575,2.319114395,Tendency towards co-occurrence
Colorectal Adenocarcinoma,FOXO4,ARHGEF10L,0.201250755,1.929289268,Tendency towards co-occurrence
Colorectal Adenocarcinoma,FOXO4,TIAM1,0.253327197,1.638425449,Tendency towards co-occurrence
Colorectal Adenocarcinoma,FOXO4,ZBTB33,0.954321145,#NAME?,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,FOXO4,RALBP1,0.672880722,#NAME?,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,CUX2,ARHGEF10L,0.154639424,1.282090584,Tendency towards co-occurrence
Colorectal Adenocarcinoma,CUX2,TIAM1,0.007644121,2.097141119,Tendency towards co-occurrence(Significant)
Colorectal Adenocarcinoma,CUX2,ZBTB33,0.853192425,#NAME?,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,CUX2,RALBP1,0.110097602,1.20804613,Tendency towards co-occurrence
Colorectal Adenocarcinoma,ARHGEF10L,TIAM1,0.378097142,0.541597282,Tendency towards co-occurrence
Colorectal Adenocarcinoma,ARHGEF10L,ZBTB33,0.798749245,#NAME?,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,ARHGEF10L,RALBP1,0.000347585,2.266653084,Tendency towards co-occurrence(Significant)
Colorectal Adenocarcinoma,TIAM1,ZBTB33,0.022925304,3.091042453,Tendency towards co-occurrence(Significant)
Colorectal Adenocarcinoma,TIAM1,RALBP1,0.613868496,-0.127058878,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,ZBTB33,RALBP1,0.327119278,1.301257318,Tendency towards co-occurrence
Breast Cancer (Cell),PTPN6,COL18A1,0.584084577,-0.168528235,Tendency towards mutual exclusivity
Breast Cancer (Cell),PTPN6,FOXO4,0.618570033,-0.108633841,Tendency towards mutual exclusivity
Breast Cancer (Cell),PTPN6,CUX2,0.522247779,0.170499818,Tendency towards co-occurrence
Breast Cancer (Cell),PTPN6,ARHGEF10L,0.030034628,1.076989825,Tendency towards co-occurrence(Significant)
Breast Cancer (Cell),PTPN6,TIAM1,0.323624453,0.379862071,Tendency towards co-occurrence
Breast Cancer (Cell),PTPN6,ZBTB33,0.005105583,1.134509898,Tendency towards co-occurrence(Significant)
Breast Cancer (Cell),PTPN6,RALBP1,0.013054382,0.925769476,Tendency towards co-occurrence(Significant)
Breast Cancer (Cell),COL18A1,FOXO4,0.49095148,-0.555569929,Tendency towards mutual exclusivity
Breast Cancer (Cell),COL18A1,CUX2,0.621273001,-0.285349127,Tendency towards mutual exclusivity
Breast Cancer (Cell),COL18A1,ARHGEF10L,0.008117342,1.411704077,Tendency towards co-occurrence(Significant)
Breast Cancer (Cell),COL18A1,TIAM1,0.623452612,-0.099888546,Tendency towards mutual exclusivity
Breast Cancer (Cell),COL18A1,ZBTB33,0.194329873,0.559476133,Tendency towards co-occurrence
Breast Cancer (Cell),COL18A1,RALBP1,0.391146754,0.238001589,Tendency towards co-occurrence
Breast Cancer (Cell),FOXO4,CUX2,0.646821505,-0.2271197,Tendency towards mutual exclusivity
Breast Cancer (Cell),FOXO4,ARHGEF10L,0.462591991,-0.610909082,Tendency towards mutual exclusivity
Breast Cancer (Cell),FOXO4,TIAM1,0.14688396,0.761946235,Tendency towards co-occurrence
Breast Cancer (Cell),FOXO4,ZBTB33,0.580871837,0.016901811,Tendency towards co-occurrence
Breast Cancer (Cell),FOXO4,RALBP1,0.442895002,-0.296634684,Tendency towards mutual exclusivity
Breast Cancer (Cell),CUX2,ARHGEF10L,0.238884655,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Cell),CUX2,TIAM1,0.511760063,-0.515129019,Tendency towards mutual exclusivity
Breast Cancer (Cell),CUX2,ZBTB33,0.191196412,0.651277459,Tendency towards co-occurrence
Breast Cancer (Cell),CUX2,RALBP1,0.402067077,-0.46536325,Tendency towards mutual exclusivity
Breast Cancer (Cell),ARHGEF10L,TIAM1,0.00580892,1.361753252,Tendency towards co-occurrence(Significant)
Breast Cancer (Cell),ARHGEF10L,ZBTB33,0.224924939,0.497838428,Tendency towards co-occurrence
Breast Cancer (Cell),ARHGEF10L,RALBP1,0.563385938,-0.088455421,Tendency towards mutual exclusivity
Breast Cancer (Cell),TIAM1,ZBTB33,0.550857397,0.041574757,Tendency towards co-occurrence
Breast Cancer (Cell),TIAM1,RALBP1,0.122074089,0.569094532,Tendency towards co-occurrence
Breast Cancer (Cell),ZBTB33,RALBP1,0.289013372,0.274611427,Tendency towards co-occurrence
Breast Cancer (Nature),PTPN6,COL18A1,0.636230167,-0.078893942,Tendency towards mutual exclusivity
Breast Cancer (Nature),PTPN6,FOXO4,0.806267448,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),PTPN6,CUX2,0.806267448,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),PTPN6,ARHGEF10L,0.423290182,0.288793801,Tendency towards co-occurrence
Breast Cancer (Nature),PTPN6,TIAM1,0.095299441,0.976762554,Tendency towards co-occurrence
Breast Cancer (Nature),PTPN6,ZBTB33,0.930885529,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),PTPN6,RALBP1,0.489006625,-0.237907172,Tendency towards mutual exclusivity
Breast Cancer (Nature),COL18A1,FOXO4,0.811905682,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),COL18A1,CUX2,0.811905682,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),COL18A1,ARHGEF10L,0.066539081,0.982982106,Tendency towards co-occurrence
Breast Cancer (Nature),COL18A1,TIAM1,0.248352653,0.644628719,Tendency towards co-occurrence
Breast Cancer (Nature),COL18A1,ZBTB33,0.933045356,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),COL18A1,RALBP1,0.515639372,-0.200194618,Tendency towards mutual exclusivity
Breast Cancer (Nature),FOXO4,CUX2,0.980645643,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),FOXO4,ARHGEF10L,0.79506941,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),FOXO4,TIAM1,0.008799758,3.592735594,Tendency towards co-occurrence(Significant)
Breast Cancer (Nature),FOXO4,ZBTB33,0.993520518,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),FOXO4,RALBP1,0.693814602,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),CUX2,ARHGEF10L,0.79506941,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),CUX2,TIAM1,0.840491433,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),CUX2,ZBTB33,0.993520518,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),CUX2,RALBP1,0.306185398,1.366876275,Tendency towards co-occurrence
Breast Cancer (Nature),ARHGEF10L,TIAM1,0.585815427,0.053244515,Tendency towards co-occurrence
Breast Cancer (Nature),ARHGEF10L,ZBTB33,0.926565875,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),ARHGEF10L,RALBP1,0.029362554,0.965325066,Tendency towards co-occurrence(Significant)
Breast Cancer (Nature),TIAM1,ZBTB33,0.943844492,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),TIAM1,RALBP1,0.020204688,1.141537333,Tendency towards co-occurrence(Significant)
Breast Cancer (Nature),ZBTB33,RALBP1,0.885529158,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,PTPN6,COL18A1,0.798666298,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,PTPN6,FOXO4,0.851825589,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,PTPN6,CUX2,0.320663733,1.054734282,Tendency towards co-occurrence
LGG+GBM,PTPN6,ARHGEF10L,0.879663027,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,PTPN6,TIAM1,0.798666298,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,PTPN6,ZBTB33,0.879663027,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,PTPN6,RALBP1,0.908372656,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,COL18A1,FOXO4,0.956582241,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,COL18A1,CUX2,0.898517453,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,COL18A1,ARHGEF10L,0.965134061,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,COL18A1,TIAM1,0.001371541,4.136126096,Tendency towards co-occurrence(Significant)
LGG+GBM,COL18A1,ZBTB33,0.965134061,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,COL18A1,RALBP1,0.97375133,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,FOXO4,CUX2,0.926503359,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,FOXO4,ARHGEF10L,0.975001187,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,FOXO4,TIAM1,0.956582241,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,FOXO4,ZBTB33,0.024998813,4.182050143,Tendency towards co-occurrence(Significant)
LGG+GBM,FOXO4,RALBP1,0.981203484,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,CUX2,ARHGEF10L,0.059206101,3.161503484,Tendency towards co-occurrence
LGG+GBM,CUX2,TIAM1,0.898517453,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,CUX2,ZBTB33,0.940793899,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,CUX2,RALBP1,0.955286231,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,ARHGEF10L,TIAM1,0.965134061,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,ARHGEF10L,ZBTB33,0.979963025,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,ARHGEF10L,RALBP1,0.984943777,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,TIAM1,ZBTB33,0.965134061,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,TIAM1,RALBP1,0.97375133,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,ZBTB33,RALBP1,0.984943777,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),PTPN6,COL18A1,0.394107193,0.828813046,Tendency towards co-occurrence
Glioblastoma (Cell),PTPN6,FOXO4,0.24665656,1.46999338,Tendency towards co-occurrence
Glioblastoma (Cell),PTPN6,CUX2,0.323991761,1.102309151,Tendency towards co-occurrence
Glioblastoma (Cell),PTPN6,ARHGEF10L,0.02040358,2.624668592,Tendency towards co-occurrence(Significant)
Glioblastoma (Cell),PTPN6,TIAM1,0.02040358,2.624668592,Tendency towards co-occurrence(Significant)
Glioblastoma (Cell),PTPN6,ZBTB33,0.780837726,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),PTPN6,RALBP1,0.868824448,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),COL18A1,FOXO4,0.670724649,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),COL18A1,CUX2,0.575705977,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),COL18A1,ARHGEF10L,0.705502964,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),COL18A1,TIAM1,0.294497036,1.245409994,Tendency towards co-occurrence
Glioblastoma (Cell),COL18A1,ZBTB33,0.705502964,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),COL18A1,RALBP1,0.820145281,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),FOXO4,CUX2,0.002045473,3.026503932,Tendency towards co-occurrence(Significant)
Glioblastoma (Cell),FOXO4,ARHGEF10L,0.012995755,2.919570913,Tendency towards co-occurrence(Significant)
Glioblastoma (Cell),FOXO4,TIAM1,0.178978451,1.886347888,Tendency towards co-occurrence
Glioblastoma (Cell),FOXO4,ZBTB33,0.012995755,2.919570913,Tendency towards co-occurrence(Significant)
Glioblastoma (Cell),FOXO4,RALBP1,0.89396101,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),CUX2,ARHGEF10L,0.024647538,2.503255788,Tendency towards co-occurrence(Significant)
Glioblastoma (Cell),CUX2,TIAM1,0.238613747,1.518783544,Tendency towards co-occurrence
Glioblastoma (Cell),CUX2,ZBTB33,0.761386253,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),CUX2,RALBP1,0.85645684,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),ARHGEF10L,TIAM1,0.00986119,3.105483138,Tendency towards co-occurrence(Significant)
Glioblastoma (Cell),ARHGEF10L,ZBTB33,0.000288969,3.96081317,Tendency towards co-occurrence(Significant)
Glioblastoma (Cell),ARHGEF10L,RALBP1,0.906731882,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),TIAM1,ZBTB33,0.158230614,2.044102175,Tendency towards co-occurrence
Glioblastoma (Cell),TIAM1,RALBP1,0.906731882,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),ZBTB33,RALBP1,0.093268118,2.747982911,Tendency towards co-occurrence
Glioblastoma (Nature),PTPN6,COL18A1,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),PTPN6,FOXO4,0.978021978,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Nature),PTPN6,CUX2,0.956288156,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Nature),PTPN6,ARHGEF10L,0.956288156,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Nature),PTPN6,TIAM1,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),PTPN6,ZBTB33,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),PTPN6,RALBP1,0.978021978,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Nature),COL18A1,FOXO4,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),COL18A1,CUX2,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),COL18A1,ARHGEF10L,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),COL18A1,TIAM1,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),COL18A1,ZBTB33,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),COL18A1,RALBP1,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),FOXO4,CUX2,0.978021978,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Nature),FOXO4,ARHGEF10L,0.978021978,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Nature),FOXO4,TIAM1,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),FOXO4,ZBTB33,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),FOXO4,RALBP1,0.989010989,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Nature),CUX2,ARHGEF10L,0.956288156,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Nature),CUX2,TIAM1,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),CUX2,ZBTB33,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),CUX2,RALBP1,0.978021978,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Nature),ARHGEF10L,TIAM1,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),ARHGEF10L,ZBTB33,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),ARHGEF10L,RALBP1,0.021978022,Infinity,Tendency towards co-occurrence(Significant)
Glioblastoma (Nature),TIAM1,ZBTB33,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),TIAM1,RALBP1,1,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),ZBTB33,RALBP1,1,Infinity,Tendency towards co-occurrence
Stomach +Esophageal Cancer,PTPN6,COL18A1,0.223899522,1.642227735,Tendency towards co-occurrence
Stomach +Esophageal Cancer,PTPN6,FOXO4,0.962550029,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,PTPN6,CUX2,0.208252335,1.733263263,Tendency towards co-occurrence
Stomach +Esophageal Cancer,PTPN6,ARHGEF10L,0.807646213,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,PTPN6,TIAM1,0.701531048,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,PTPN6,ZBTB33,0.891015771,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,PTPN6,RALBP1,0.745548239,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,COL18A1,FOXO4,0.904116638,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,COL18A1,CUX2,0.460359171,0.601995011,Tendency towards co-occurrence
Stomach +Esophageal Cancer,COL18A1,ARHGEF10L,0.568750085,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,COL18A1,TIAM1,0.049080872,1.556037136,Tendency towards co-occurrence(Significant)
Stomach +Esophageal Cancer,COL18A1,ZBTB33,0.262704546,1.415043774,Tendency towards co-occurrence
Stomach +Esophageal Cancer,COL18A1,RALBP1,0.539641553,0.348306694,Tendency towards co-occurrence
Stomach +Esophageal Cancer,FOXO4,CUX2,0.911320755,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,FOXO4,ARHGEF10L,0.918553459,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,FOXO4,TIAM1,0.868524871,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,FOXO4,ZBTB33,0.955145798,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,FOXO4,RALBP1,0.889794168,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,CUX2,ARHGEF10L,0.082403763,1.690505736,Tendency towards co-occurrence
Stomach +Esophageal Cancer,CUX2,TIAM1,0.039445013,1.665608184,Tendency towards co-occurrence(Significant)
Stomach +Esophageal Cancer,CUX2,ZBTB33,0.244794535,1.506095561,Tendency towards co-occurrence
Stomach +Esophageal Cancer,CUX2,RALBP1,0.489372635,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,ARHGEF10L,TIAM1,0.545841273,0.332261704,Tendency towards co-occurrence
Stomach +Esophageal Cancer,ARHGEF10L,ZBTB33,0.773476565,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,ARHGEF10L,RALBP1,0.479913601,0.538996501,Tendency towards co-occurrence
Stomach +Esophageal Cancer,TIAM1,ZBTB33,0.347036486,1.04628647,Tendency towards co-occurrence
Stomach +Esophageal Cancer,TIAM1,RALBP1,0.337855356,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,ZBTB33,RALBP1,0.702535841,#NAME?,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,PTPN6,COL18A1,0.584166763,0.072320662,Tendency towards co-occurrence
Stomach Adenocarcinoma,PTPN6,FOXO4,0.558001136,-0.435318071,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,PTPN6,CUX2,0.483920114,-0.588810206,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,PTPN6,ARHGEF10L,0.671349595,-0.013986242,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,PTPN6,TIAM1,0.527335983,-0.277925898,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,PTPN6,ZBTB33,0.287402746,0.587786665,Tendency towards co-occurrence
Stomach Adenocarcinoma,PTPN6,RALBP1,0.084423321,#NAME?,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,COL18A1,FOXO4,0.088725152,#NAME?,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,COL18A1,CUX2,0.088781981,0.930542755,Tendency towards co-occurrence
Stomach Adenocarcinoma,COL18A1,ARHGEF10L,0.640430457,-0.014528101,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,COL18A1,TIAM1,0.460473638,-0.287682072,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,COL18A1,ZBTB33,0.557482352,0.075223421,Tendency towards co-occurrence
Stomach Adenocarcinoma,COL18A1,RALBP1,0.438222785,0.231801614,Tendency towards co-occurrence
Stomach Adenocarcinoma,FOXO4,CUX2,0.395202121,-0.765250474,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,FOXO4,ARHGEF10L,0.070228976,1.020087526,Tendency towards co-occurrence
Stomach Adenocarcinoma,FOXO4,TIAM1,0.333202725,0.410355093,Tendency towards co-occurrence
Stomach Adenocarcinoma,FOXO4,ZBTB33,0.088725152,#NAME?,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,FOXO4,RALBP1,0.00772574,1.444563269,Tendency towards co-occurrence(Significant)
Stomach Adenocarcinoma,CUX2,ARHGEF10L,0.216563132,-1.139822557,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,CUX2,TIAM1,0.228876788,0.544217708,Tendency towards co-occurrence
Stomach Adenocarcinoma,CUX2,ZBTB33,0.026645561,1.218157439,Tendency towards co-occurrence(Significant)
Stomach Adenocarcinoma,CUX2,RALBP1,0.159195182,0.701880861,Tendency towards co-occurrence
Stomach Adenocarcinoma,ARHGEF10L,TIAM1,0.086779338,0.785889232,Tendency towards co-occurrence
Stomach Adenocarcinoma,ARHGEF10L,ZBTB33,0.169685494,0.673060422,Tendency towards co-occurrence
Stomach Adenocarcinoma,ARHGEF10L,RALBP1,0.129389559,0.711374694,Tendency towards co-occurrence
Stomach Adenocarcinoma,TIAM1,ZBTB33,0.020220116,1.116004031,Tendency towards co-occurrence(Significant)
Stomach Adenocarcinoma,TIAM1,RALBP1,0.472225457,0.152613401,Tendency towards co-occurrence
Stomach Adenocarcinoma,ZBTB33,RALBP1,0.317980348,-0.623621118,Tendency towards mutual exclusivity
Head and Neck Cancer,PTPN6,COL18A1,0.160846764,1.211940974,Tendency towards co-occurrence
Head and Neck Cancer,PTPN6,FOXO4,0.013834163,1.773848543,Tendency towards co-occurrence(Significant)
Head and Neck Cancer,PTPN6,CUX2,0.698841289,-0.104543856,Tendency towards mutual exclusivity
Head and Neck Cancer,PTPN6,ARHGEF10L,0.675049458,-0.165792255,Tendency towards mutual exclusivity
Head and Neck Cancer,PTPN6,TIAM1,0.324950542,0.653141846,Tendency towards co-occurrence
Head and Neck Cancer,PTPN6,ZBTB33,0.009427899,1.673153727,Tendency towards co-occurrence(Significant)
Head and Neck Cancer,PTPN6,RALBP1,0.145907167,#NAME?,Tendency towards mutual exclusivity
Head and Neck Cancer,COL18A1,FOXO4,0.4629175,#NAME?,Tendency towards mutual exclusivity
Head and Neck Cancer,COL18A1,CUX2,0.558284829,0.290352301,Tendency towards co-occurrence
Head and Neck Cancer,COL18A1,ARHGEF10L,0.578593572,0.229185866,Tendency towards co-occurrence
Head and Neck Cancer,COL18A1,TIAM1,0.421406428,#NAME?,Tendency towards mutual exclusivity
Head and Neck Cancer,COL18A1,ZBTB33,0.275903069,0.800777845,Tendency towards co-occurrence
Head and Neck Cancer,COL18A1,RALBP1,0.360273641,0.575364145,Tendency towards co-occurrence
Head and Neck Cancer,FOXO4,CUX2,0.08659702,1.260893095,Tendency towards co-occurrence
Head and Neck Cancer,FOXO4,ARHGEF10L,0.098928151,1.192297773,Tendency towards co-occurrence
Head and Neck Cancer,FOXO4,TIAM1,0.324950542,0.653141846,Tendency towards co-occurrence
Head and Neck Cancer,FOXO4,ZBTB33,0.04691145,1.314550456,Tendency towards co-occurrence(Significant)
Head and Neck Cancer,FOXO4,RALBP1,0.453309872,-0.649472117,Tendency towards mutual exclusivity
Head and Neck Cancer,CUX2,ARHGEF10L,0.648629856,-0.230523659,Tendency towards mutual exclusivity
Head and Neck Cancer,CUX2,TIAM1,0.351370144,0.58451334,Tendency towards co-occurrence
Head and Neck Cancer,CUX2,ZBTB33,0.471679102,0.305979557,Tendency towards co-occurrence
Head and Neck Cancer,CUX2,RALBP1,0.283872547,0.592051064,Tendency towards co-occurrence
Head and Neck Cancer,ARHGEF10L,TIAM1,0.030994511,1.471452169,Tendency towards co-occurrence(Significant)
Head and Neck Cancer,ARHGEF10L,ZBTB33,0.170414986,#NAME?,Tendency towards mutual exclusivity
Head and Neck Cancer,ARHGEF10L,RALBP1,0.61072859,0.015135424,Tendency towards co-occurrence
Head and Neck Cancer,TIAM1,ZBTB33,0.501697953,0.241162057,Tendency towards co-occurrence
Head and Neck Cancer,TIAM1,RALBP1,0.120744394,0.918953849,Tendency towards co-occurrence
Head and Neck Cancer,ZBTB33,RALBP1,0.25835964,-1.042748709,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,PTPN6,COL18A1,0.937519348,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,PTPN6,FOXO4,0.962125151,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,PTPN6,CUX2,1,Infinity,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,PTPN6,ARHGEF10L,0.949758504,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,PTPN6,TIAM1,0.962125151,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,PTPN6,ZBTB33,0.889817947,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,PTPN6,RALBP1,0.937519348,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,COL18A1,FOXO4,0.000389453,5.550372261,Tendency towards co-occurrence(Significant)
Kidney Clear Cell Carcinoma,COL18A1,CUX2,1,Infinity,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,COL18A1,ARHGEF10L,0.000774907,4.854631046,Tendency towards co-occurrence(Significant)
Kidney Clear Cell Carcinoma,COL18A1,TIAM1,0.962125151,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,COL18A1,ZBTB33,0.004530846,3.588795996,Tendency towards co-occurrence(Significant)
Kidney Clear Cell Carcinoma,COL18A1,RALBP1,0.001284872,4.446565156,Tendency towards co-occurrence(Significant)
Kidney Clear Cell Carcinoma,FOXO4,CUX2,1,Infinity,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,FOXO4,ARHGEF10L,0.03037777,4.1640779,Tendency towards co-occurrence(Significant)
Kidney Clear Cell Carcinoma,FOXO4,TIAM1,0.977158154,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,FOXO4,ZBTB33,0.067476723,3.170210653,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,FOXO4,RALBP1,0.000389453,5.550372261,Tendency towards co-occurrence(Significant)
Kidney Clear Cell Carcinoma,CUX2,ARHGEF10L,1,Infinity,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,CUX2,TIAM1,1,Infinity,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,CUX2,ZBTB33,1,Infinity,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,CUX2,RALBP1,1,Infinity,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,ARHGEF10L,TIAM1,0.96962223,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,ARHGEF10L,ZBTB33,0.002751457,3.996889226,Tendency towards co-occurrence(Significant)
Kidney Clear Cell Carcinoma,ARHGEF10L,RALBP1,0.000774907,4.854631046,Tendency towards co-occurrence(Significant)
Kidney Clear Cell Carcinoma,TIAM1,ZBTB33,0.932523277,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,TIAM1,RALBP1,0.037874849,3.873801793,Tendency towards co-occurrence(Significant)
Kidney Clear Cell Carcinoma,ZBTB33,RALBP1,0.110182053,2.471800302,Tendency towards co-occurrence
Lung Adenocarcinoma,PTPN6,COL18A1,0.53191518,0.092742052,Tendency towards co-occurrence
Lung Adenocarcinoma,PTPN6,FOXO4,0.54763539,-0.244883538,Tendency towards mutual exclusivity
Lung Adenocarcinoma,PTPN6,CUX2,0.367246635,0.432864082,Tendency towards co-occurrence
Lung Adenocarcinoma,PTPN6,ARHGEF10L,0.076890213,1.012682578,Tendency towards co-occurrence
Lung Adenocarcinoma,PTPN6,TIAM1,0.627545976,-0.005763705,Tendency towards mutual exclusivity
Lung Adenocarcinoma,PTPN6,ZBTB33,0.573529883,-0.122167634,Tendency towards mutual exclusivity
Lung Adenocarcinoma,PTPN6,RALBP1,0.53191518,0.092742052,Tendency towards co-occurrence
Lung Adenocarcinoma,COL18A1,FOXO4,0.298255158,0.571084815,Tendency towards co-occurrence
Lung Adenocarcinoma,COL18A1,CUX2,0.475062279,-0.610909082,Tendency towards mutual exclusivity
Lung Adenocarcinoma,COL18A1,ARHGEF10L,0.029819442,1.337504197,Tendency towards co-occurrence(Significant)
Lung Adenocarcinoma,COL18A1,TIAM1,0.141396409,-1.338562958,Tendency towards mutual exclusivity
Lung Adenocarcinoma,COL18A1,ZBTB33,0.502536854,-0.319942935,Tendency towards mutual exclusivity
Lung Adenocarcinoma,COL18A1,RALBP1,0.411947407,-0.470003629,Tendency towards mutual exclusivity
Lung Adenocarcinoma,FOXO4,CUX2,0.304246144,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,FOXO4,ARHGEF10L,0.636318148,-0.261973716,Tendency towards mutual exclusivity
Lung Adenocarcinoma,FOXO4,TIAM1,0.00912167,1.555095171,Tendency towards co-occurrence(Significant)
Lung Adenocarcinoma,FOXO4,ZBTB33,0.52581112,0.198069914,Tendency towards co-occurrence
Lung Adenocarcinoma,FOXO4,RALBP1,0.298255158,0.571084815,Tendency towards co-occurrence
Lung Adenocarcinoma,CUX2,ARHGEF10L,0.694109294,-0.118341227,Tendency towards mutual exclusivity
Lung Adenocarcinoma,CUX2,TIAM1,0.092972299,1.062618686,Tendency towards co-occurrence
Lung Adenocarcinoma,CUX2,ZBTB33,0.009821955,1.69968479,Tendency towards co-occurrence(Significant)
Lung Adenocarcinoma,CUX2,RALBP1,0.232258531,0.735706795,Tendency towards co-occurrence
Lung Adenocarcinoma,ARHGEF10L,TIAM1,0.359266701,-0.842678915,Tendency towards mutual exclusivity
Lung Adenocarcinoma,ARHGEF10L,ZBTB33,0.47418888,-0.611357748,Tendency towards mutual exclusivity
Lung Adenocarcinoma,ARHGEF10L,RALBP1,0.109410879,0.982575978,Tendency towards co-occurrence
Lung Adenocarcinoma,TIAM1,ZBTB33,0.128575172,0.798507696,Tendency towards co-occurrence
Lung Adenocarcinoma,TIAM1,RALBP1,0.192204636,0.62791829,Tendency towards co-occurrence
Lung Adenocarcinoma,ZBTB33,RALBP1,0.099139852,0.900290391,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,PTPN6,COL18A1,0.440365052,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,PTPN6,FOXO4,0.261352816,1.603168299,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,PTPN6,CUX2,0.170741135,1.236762627,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,PTPN6,ARHGEF10L,0.488976779,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,PTPN6,TIAM1,0.118862883,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,PTPN6,ZBTB33,0.904494382,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,PTPN6,RALBP1,0.231691789,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,COL18A1,FOXO4,0.870440262,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,COL18A1,CUX2,0.04333646,2.20949467,Tendency towards co-occurrence(Significant)
Lung Squamous Cell Carcinoma,COL18A1,ARHGEF10L,0.279341563,1.36219681,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,COL18A1,TIAM1,0.377556393,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,COL18A1,ZBTB33,0.95505618,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,COL18A1,RALBP1,0.487867549,0.545386299,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,FOXO4,CUX2,0.870440262,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,FOXO4,ARHGEF10L,0.885983839,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,FOXO4,TIAM1,0.697871401,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,FOXO4,ZBTB33,0.983146067,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,FOXO4,RALBP1,0.780981112,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,CUX2,ARHGEF10L,0.720658437,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,CUX2,TIAM1,0.222383852,1.034896474,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,CUX2,ZBTB33,0.95505618,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,CUX2,RALBP1,0.01731515,2.160183306,Tendency towards co-occurrence(Significant)
Lung Squamous Cell Carcinoma,ARHGEF10L,TIAM1,0.572436137,0.287682072,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,ARHGEF10L,ZBTB33,0.960674157,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,ARHGEF10L,RALBP1,0.442199687,0.705886206,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,TIAM1,ZBTB33,0.887640449,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,TIAM1,RALBP1,0.055639757,1.30833282,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,ZBTB33,RALBP1,0.921348315,#NAME?,Tendency towards mutual exclusivity
Ovarian Serous Cancer,PTPN6,COL18A1,0.406200391,-0.478035801,Tendency towards mutual exclusivity
Ovarian Serous Cancer,PTPN6,FOXO4,1,Infinity,Tendency towards co-occurrence
Ovarian Serous Cancer,PTPN6,CUX2,0.464911678,0.191268343,Tendency towards co-occurrence
Ovarian Serous Cancer,PTPN6,ARHGEF10L,0.127113109,-1.375006401,Tendency towards mutual exclusivity
Ovarian Serous Cancer,PTPN6,TIAM1,0.259557149,-1.049422044,Tendency towards mutual exclusivity
Ovarian Serous Cancer,PTPN6,ZBTB33,0.302471368,1.640328399,Tendency towards co-occurrence
Ovarian Serous Cancer,PTPN6,RALBP1,0.049559485,0.77908961,Tendency towards co-occurrence(Significant)
Ovarian Serous Cancer,COL18A1,FOXO4,1,Infinity,Tendency towards co-occurrence
Ovarian Serous Cancer,COL18A1,CUX2,0.6602691,-0.201324504,Tendency towards mutual exclusivity
Ovarian Serous Cancer,COL18A1,ARHGEF10L,0.095924104,1.195703413,Tendency towards co-occurrence
Ovarian Serous Cancer,COL18A1,TIAM1,0.207265383,1.008098281,Tendency towards co-occurrence
Ovarian Serous Cancer,COL18A1,ZBTB33,0.88915009,#NAME?,Tendency towards mutual exclusivity
Ovarian Serous Cancer,COL18A1,RALBP1,0.04117513,1.197750009,Tendency towards co-occurrence(Significant)
Ovarian Serous Cancer,FOXO4,CUX2,1,Infinity,Tendency towards co-occurrence
Ovarian Serous Cancer,FOXO4,ARHGEF10L,1,Infinity,Tendency towards co-occurrence
Ovarian Serous Cancer,FOXO4,TIAM1,1,Infinity,Tendency towards co-occurrence
Ovarian Serous Cancer,FOXO4,ZBTB33,1,Infinity,Tendency towards co-occurrence
Ovarian Serous Cancer,FOXO4,RALBP1,1,Infinity,Tendency towards co-occurrence
Ovarian Serous Cancer,CUX2,ARHGEF10L,0.241700789,#NAME?,Tendency towards mutual exclusivity
Ovarian Serous Cancer,CUX2,TIAM1,0.347867486,#NAME?,Tendency towards mutual exclusivity
Ovarian Serous Cancer,CUX2,ZBTB33,0.871308017,#NAME?,Tendency towards mutual exclusivity
Ovarian Serous Cancer,CUX2,RALBP1,0.000902308,1.769536332,Tendency towards co-occurrence(Significant)
Ovarian Serous Cancer,ARHGEF10L,TIAM1,0.633563076,0.058410762,Tendency towards co-occurrence
Ovarian Serous Cancer,ARHGEF10L,ZBTB33,0.877235282,#NAME?,Tendency towards mutual exclusivity
Ovarian Serous Cancer,ARHGEF10L,RALBP1,0.082091676,#NAME?,Tendency towards mutual exclusivity
Ovarian Serous Cancer,TIAM1,ZBTB33,0.907172996,#NAME?,Tendency towards mutual exclusivity
Ovarian Serous Cancer,TIAM1,RALBP1,0.527570694,0.189085957,Tendency towards co-occurrence
Ovarian Serous Cancer,ZBTB33,RALBP1,0.215189873,2.07586372,Tendency towards co-occurrence
Prostate Adenocarcinoma,PTPN6,COL18A1,0.478955454,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,PTPN6,FOXO4,0.640892374,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,PTPN6,CUX2,0.540810962,0.33514861,Tendency towards co-occurrence
Prostate Adenocarcinoma,PTPN6,ARHGEF10L,0.578104127,0.223143551,Tendency towards co-occurrence
Prostate Adenocarcinoma,PTPN6,TIAM1,0.695681658,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,PTPN6,ZBTB33,0.521044546,0.395612812,Tendency towards co-occurrence
Prostate Adenocarcinoma,PTPN6,RALBP1,0.615017837,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,COL18A1,FOXO4,0.537452163,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,COL18A1,CUX2,0.726028128,-0.029852963,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,COL18A1,ARHGEF10L,0.003056801,1.972343406,Tendency towards co-occurrence(Significant)
Prostate Adenocarcinoma,COL18A1,TIAM1,0.397348723,0.814192862,Tendency towards co-occurrence
Prostate Adenocarcinoma,COL18A1,ZBTB33,0.35790119,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,COL18A1,RALBP1,0.507408253,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,FOXO4,CUX2,0.518683992,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,FOXO4,ARHGEF10L,0.025777393,1.84582669,Tendency towards co-occurrence(Significant)
Prostate Adenocarcinoma,FOXO4,TIAM1,0.736330052,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,FOXO4,ZBTB33,0.462547837,0.58451334,Tendency towards co-occurrence
Prostate Adenocarcinoma,FOXO4,RALBP1,0.663633716,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,CUX2,ARHGEF10L,0.659586047,-0.202524264,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,CUX2,TIAM1,0.585432669,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,CUX2,ZBTB33,0.337449693,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,CUX2,RALBP1,0.511921585,0.425465775,Tendency towards co-occurrence
Prostate Adenocarcinoma,ARHGEF10L,TIAM1,0.552301715,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,ARHGEF10L,ZBTB33,0.316022481,0.666478933,Tendency towards co-occurrence
Prostate Adenocarcinoma,ARHGEF10L,RALBP1,0.451428584,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,TIAM1,ZBTB33,0.397348723,0.814192862,Tendency towards co-occurrence
Prostate Adenocarcinoma,TIAM1,RALBP1,0.715749399,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,ZBTB33,RALBP1,0.021542645,1.916922612,Tendency towards co-occurrence(Significant)
Papillary Thyroid Carcinoma,PTPN6,COL18A1,0.377297989,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,PTPN6,FOXO4,0.19648883,1.033015006,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,PTPN6,CUX2,0.254872518,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,PTPN6,ARHGEF10L,0.377297989,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,PTPN6,TIAM1,0.337559139,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,PTPN6,ZBTB33,0.684526025,-0.139636637,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,PTPN6,RALBP1,0.19648883,1.033015006,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,COL18A1,FOXO4,0.539529638,0.330854244,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,COL18A1,CUX2,0.674544385,-0.164828399,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,COL18A1,ARHGEF10L,0.583070332,0.200041369,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,COL18A1,TIAM1,0.377297989,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,COL18A1,ZBTB33,0.271558091,0.782759339,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,COL18A1,RALBP1,0.032174226,1.703348512,Tendency towards co-occurrence(Significant)
Papillary Thyroid Carcinoma,FOXO4,CUX2,0.337042632,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,FOXO4,ARHGEF10L,0.539529638,0.330854244,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,FOXO4,TIAM1,0.578544661,0.213978877,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,FOXO4,ZBTB33,0.227789567,0.921988753,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,FOXO4,RALBP1,0.497148001,0.46163538,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,CUX2,ARHGEF10L,3.85047E-05,2.521274294,Tendency towards co-occurrence(Significant)
Papillary Thyroid Carcinoma,CUX2,TIAM1,0.254872518,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,CUX2,ZBTB33,0.221375397,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,CUX2,RALBP1,0.275552043,0.773667557,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,ARHGEF10L,TIAM1,0.622702011,0.0831339,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,ARHGEF10L,ZBTB33,0.341243257,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,ARHGEF10L,RALBP1,0.539529638,0.330854244,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,TIAM1,ZBTB33,0.09607653,1.176031888,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,TIAM1,RALBP1,0.421455339,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,ZBTB33,RALBP1,0.614444008,0.108213585,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,PTPN6,COL18A1,0.498642535,-0.561087459,Tendency towards mutual exclusivity
Uterine Corpus Endometrial Cancer,PTPN6,FOXO4,0.19286376,0.840552472,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,PTPN6,CUX2,0.235865392,0.719122667,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,PTPN6,ARHGEF10L,0.042879732,1.210941474,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,PTPN6,TIAM1,0.349907902,0.459532329,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,PTPN6,ZBTB33,0.214081427,0.778304989,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,PTPN6,RALBP1,0.553601007,0.13872621,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,COL18A1,FOXO4,0.023446404,1.406913648,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,COL18A1,CUX2,0.122319237,0.925399448,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,COL18A1,ARHGEF10L,0.546949396,-0.24442095,Tendency towards mutual exclusivity
Uterine Corpus Endometrial Cancer,COL18A1,TIAM1,0.215415405,0.654028764,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,COL18A1,ZBTB33,0.028919682,1.337260027,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,COL18A1,RALBP1,0.139181562,0.86613741,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,FOXO4,CUX2,0.290942489,0.583650154,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,FOXO4,ARHGEF10L,0.017435058,1.36045313,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,FOXO4,TIAM1,0.017435058,1.36045313,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,FOXO4,ZBTB33,7.28009E-05,2.322890359,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,FOXO4,RALBP1,0.034496187,1.278874112,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,CUX2,ARHGEF10L,0.093782223,0.921624078,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,CUX2,TIAM1,0.00671333,1.489151747,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,CUX2,ZBTB33,0.0351681,1.271494005,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,CUX2,RALBP1,0.158787678,0.803757052,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,ARHGEF10L,TIAM1,0.005790919,1.416310257,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,ARHGEF10L,ZBTB33,0.004977544,1.563393974,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,ARHGEF10L,RALBP1,0.110064337,0.859132318,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,TIAM1,ZBTB33,1.29672E-05,2.339334635,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,TIAM1,RALBP1,0.035166613,1.15046565,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,ZBTB33,RALBP1,0.001740056,1.807263656,Tendency towards co-occurrence(Significant)